Literature DB >> 21272931

pH-responsive endosomolytic pseudo-peptides for drug delivery to multicellular spheroids tumour models.

Vincent H B Ho1, Nigel K H Slater, Rongjun Chen.   

Abstract

Endosomolytic polymers can aid in the endosomal release of therapeutics to improve intracellular drug delivery. pH-responsive biomimetic pseudo-peptides were synthesised by grafting l-phenylalanine onto the pendant carboxylic acids of a polyamide, poly(l-lysine isophthalamide). PP-75 (stoichiometric l-phenylalanine grafting of 75 mol%) was determined to have the best endosomolytic property. The mean hydrodynamic size of PP-75 decreased with lower pH as the polymers adopted a more compact conformation due to protonation of acidic groups and increase in hydrophobicity. PP-75 was demonstrated to deliver model drugs effectively in three dimensional (3D) magnetic HeLa multicellular spheroids used as in vitro tumour models. These spheroids can be isolated easily and quickly by magnetic separation. Due to its relatively small size, PP-75 was able to penetrate from the exterior to the interior of these spheroids and was internalised by the cells in the spheroids. It could retain its pH-mediated membrane-lytic capability in 3D drug delivery by releasing internalised calcein from intracellular endosomes in the tumour models. Furthermore, cell viability results suggest that PP-75 showed no significant cytotoxicity towards cells in the spheroids. The pH-responsive PP-75 can potentially enhance the extracellular and intracellular delivery of therapeutics in tumours.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272931     DOI: 10.1016/j.biomaterials.2011.01.010

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  3D tumour models: novel in vitro approaches to cancer studies.

Authors:  Agata Nyga; Umber Cheema; Marilena Loizidou
Journal:  J Cell Commun Signal       Date:  2011-04-16       Impact factor: 5.782

Review 2.  Three-dimensional in vitro tumor models for cancer research and drug evaluation.

Authors:  Xian Xu; Mary C Farach-Carson; Xinqiao Jia
Journal:  Biotechnol Adv       Date:  2014-08-10       Impact factor: 14.227

Review 3.  Amphiphilic macromolecules on cell membranes: from protective layers to controlled permeabilization.

Authors:  E Marie; S Sagan; S Cribier; C Tribet
Journal:  J Membr Biol       Date:  2014-06-06       Impact factor: 1.843

4.  Preparation and characterization of nanoparticles based on histidine-hyaluronic acid conjugates as doxorubicin carriers.

Authors:  Jing-liang Wu; Chen-guang Liu; Xiao-lei Wang; Zhen-hua Huang
Journal:  J Mater Sci Mater Med       Date:  2012-05-12       Impact factor: 3.896

5.  Endosomolytic anionic polymer for the cytoplasmic delivery of siRNAs in localized in vivo applications.

Authors:  Sariah Khormaee; Yong Choi; Michael J Shen; Biying Xu; Haitao Wu; Gary L Griffiths; Rongjun Chen; Nigel K H Slater; John K Park
Journal:  Adv Funct Mater       Date:  2013-02-05       Impact factor: 18.808

6.  Penetration of endothelial cell coated multicellular tumor spheroids by iron oxide nanoparticles.

Authors:  Don N Ho; Nathan Kohler; Aruna Sigdel; Raghu Kalluri; Jeffrey R Morgan; Chenjie Xu; Shouheng Sun
Journal:  Theranostics       Date:  2012-01-01       Impact factor: 11.556

7.  Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells.

Authors:  Michelli B Antonow; Camila Franco; Willian Prado; Aline Beckenkamp; Gustavo P Silveira; Andréia Buffon; Sílvia S Guterres; Adriana R Pohlmann
Journal:  Nanomaterials (Basel)       Date:  2017-12-22       Impact factor: 5.076

Review 8.  pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications.

Authors:  Rimesh Augustine; Nagendra Kalva; Ho An Kim; Yu Zhang; Il Kim
Journal:  Molecules       Date:  2019-08-15       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.